Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adagene
Biotech
Sanofi takes up option on Adagene biospecific, invests $25M
Sanofi is investing $25 million in the biotech, taking up its option on a third program and agreeing to sponsor a trial of its partner’s lead asset.
Nick Paul Taylor
Jul 1, 2025 8:10am
ADC Therapeutics calls it quits on Adagene solid tumor collab
Aug 31, 2023 10:24am
Sanofi looks for a 'safe' bet in $2.5B tie up for Adagene tech
Mar 2, 2022 6:00am
Adagene plans $125M IPO to challenge BMS and Pfizer
Jan 20, 2021 9:00am
China's Adagene bags $69M to advance lead immunotherapies
Jan 8, 2020 7:30am
Adagene bags $50M to take anticancer antibodies into the clinic
Mar 27, 2018 9:25am
